http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2514345-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56c13ce337340fd50f39562868ca87c2
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
filingDate 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952b365a0ecd98ed526523a3b12803b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01159bd8d06504ca5c7cc0edf1413252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f09c6c86e4fd587219334ac31b59b13
publicationDate 2014-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2514345-C1
titleOfInvention Method for prediction of degree of risk of haemorrhagic complications accompanying minimally invasive liver surgeries
abstract FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely surgery, and can be used to evaluate and predict a risk of the haemorrhagic complications accompanying minimally invasive liver surgeries. The presence of the following signs (risk predictors) is scored pre- and intraoperatively in each person individually: evident or latent coagulopathy (CP), hepatic fibrosis or cirrhosis (HC), acute hepatic failure and/or evident cholestasis (CS), technical problems of the surgery (TP), a puncture canal diameter exceeding 1.6 mm (CD), multiple instrument passage through a parenchyma (IP), a dangerous location of a mass lesion (DL) and intra- and postoperative restlessness (R). A haemorrhagic complication risk index (HCRI) is calculated by formula HCRI=CP+HC+CS+TP+CD+IP+DL+R; the derived HCRI <4 points stands for a minimum risk; the HCRI falling within the range of 5-12 points shows a moderate risk, and the surgery is preceded by prescribing a haemostatic course; if the HCRI exceeds 12 points, a high risk of the complications is stated. n EFFECT: method enables more effective prediction of the haemorrhagic complications following the minimally invasive liver surgeries that is necessary for specifying further preventative options. n 1 tbl, 2 ex
priorityDate 2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2205780-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2189598-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCAAC63054
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29251
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451114410
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8458
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00734
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ19AZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID250453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID325881
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID14061
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27367
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43736
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2147
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395306
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451158
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5R537

Total number of triples: 41.